Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system. Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity to the protein networks implicated in neurodegeneration and parkinsonism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar phenotype has also been described in the context of loss‐of‐function mutations in the P‐type ATPase gene ATP13A2, in which recessive, early‐onset PD has been linked to defective acidification of lysosomes and insufficient autophagy (Ramirez et al, 2006).”
From Autophagy in major human diseases (2021) · cites this paper as Ramirez et al, 2006
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“By mutation screening or linkage analysis, we excluded the known autosomal recessive Parkinson disease genes and loci: PARK2 (also known as Parkin ; ref”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Evolution of Substrate Specificities in the P-Type ATPase Superfamily
Axelsen, K. B., & Palmgren, M. G. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00006286 · Cited by 910
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Cited by
Items 201–300 of 1,000
C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease
Harrington, A. J., Hamamichi, S., Caldwell, G. A., & Caldwell, K. A. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22231 · Cited by 174
The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders
Velayati, A., Yu, W. H., & Sidransky, E. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0102-x · Cited by 145
New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
Nuñez, M. T., & Chana-Cuevas, P. (2018) · Pharmaceuticals · doi:10.3390/ph11040109 · Cited by 152
Gu, Z., Nakamura, T., & Lipton, S. A. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8113-9 · Cited by 151
What causes cell death in Parkinson's disease?
Gupta, A., Dawson, V. L., & Dawson, T. M. (2009) · Annals of Neurology · doi:10.1002/ana.21573 · Cited by 143
Schultheis, P. J., Fleming, S. M., Clippinger, A. K., Lewis, J., Tsunemi, T., Giasson, B., Dickson, D. W., Mazzulli, J. R., Bardgett, M. E., Haik, K. L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt057 · Cited by 143
“LRRK2: Autophagy and Lysosomal Activity”
Madureira, M., Connor-Robson, N., & Wade-Martins, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00498 · Cited by 137
Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes
Pretegiani, E., & Optican, L. M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00592 · Cited by 160
Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-24 · Cited by 142
Karimi-Moghadam, A., Charsouei, S., Bell, B., & Jabalameli, M. R. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0587-4 · Cited by 136
Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 138
Rapid selection of cyclic peptides that reduce α-synuclein toxicity in yeast and animal models
Kritzer, J. A., Hamamichi, S., McCaffery, J. M., Santagata, S., Naumann, T. A., Caldwell, K. A., Caldwell, G. A., & Lindquist, S. L. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.193 · Cited by 155
A Mitocentric View of Parkinson's Disease
Haelterman, N. A., Yoon, W. H., Sandoval, H., Jaiswal, M., Shulman, J. M., & Bellen, H. J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014317 · Cited by 144
Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
A. Schneider, S., Dusek, P., Hardy, J., Westenberger, A., Jankovic, J., & P. Bhatia, K. (2013) · Current Neuropharmacology · doi:10.2174/157015913804999469 · Cited by 139
Autophagy impairment in Parkinson’s disease
Karabiyik, C., Lee, M. J., & Rubinsztein, D. C. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170023 · Cited by 140
Neurodegeneration with brain iron accumulation–clinical syndromes and neuroimaging
Schipper, H. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.016 · Cited by 141
The Emerging Role of the Lysosome in Parkinson’s Disease
Navarro-Romero, A., Montpeyó, M., & Martinez-Vicente, M. (2020) · Cells · doi:10.3390/cells9112399 · Cited by 135
Arber, C. E., Li, A., Houlden, H., & Wray, S. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12242 · Cited by 131
Role of the endolysosomal system in Parkinson’s disease
Vidyadhara, D. J., Lee, J. E., & Chandra, S. S. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14820 · Cited by 136
Grünewald, A., Arns, B., Seibler, P., Rakovic, A., Münchau, A., Ramirez, A., Sue, C. M., & Klein, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.035 · Cited by 134
Exosomes in Parkinson’s Disease
Wu, X., Zheng, T., & Zhang, B. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0092-z · Cited by 143
The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy
Shacka, J. (2008) · Frontiers in Bioscience · doi:10.2741/2714 · Cited by 134
Cell biology and function of neuronal ceroid lipofuscinosis-related proteins
Kollmann, K., Uusi-Rauva, K., Scifo, E., Tyynelä, J., Jalanko, A., & Braulke, T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.019 · Cited by 150
Bras, J., Singleton, A., Cookson, M. R., & Hardy, J. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06709.x · Cited by 132
Di Domenico, F., Coccia, R., Cocciolo, A., Murphy, M. P., Cenini, G., Head, E., Butterfield, D. A., Giorgi, A., Schinina, M. E., Mancuso, C., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.013 · Cited by 134
Dystonia: diagnosis and management
Albanese, A., Giovanni, M. D., & Lalli, S. (2018) · European Journal of Neurology · doi:10.1111/ene.13762 · Cited by 133
Impact of gene mutation in the development of Parkinson's disease
Selvaraj, S., & Piramanayagam, S. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.01.004 · Cited by 140
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Valera, E., & Masliah, E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.013 · Cited by 132
“…genes, vacuolar protein sorting 35 (VPS35) and eukaryotic translation initiation factor 4G1 (EIF4G1) (Chartier-Harlin et al., 2011; Lesage & Brice, 2012; Matsumine et al., 1998; Ramirez et al., 2006; Valente et al., 2012; van Duijn et al., 2001; Zimprich et al., 2011; Zimprich et al., 2004).”
BackgroundSphingolipids in the Pathogenesis of Parkinson’s Disease and Parkinsonism
Lin, G., Wang, L., Marcogliese, P. C., & Bellen, H. J. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.11.003 · Cited by 126
Farias, F. H. G., Zeng, R., Johnson, G. S., Wininger, F. A., Taylor, J. F., Schnabel, R. D., McKay, S. D., Sanders, D. N., Lohi, H., Seppälä, E. H., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.02.009 · Cited by 127
Schmidt, K., Wolfe, D. M., Stiller, B., & Pearce, D. A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.151 · Cited by 126
Self-citationBenedetto, A., Au, C., & Aschner, M. (2009) · Chemical Reviews · doi:10.1021/cr800536y · Cited by 128
Lysosomal adaptation: how the lysosome responds to external cues
Settembre, C., & Ballabio, A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016907 · Cited by 126
“Additional mutations in genes involved in the endolysosomal pathway have been identified in patients with late-onset neurodegenerative diseases (Verhoeven et al. 2003; Skibinski et al. 2005; Ramirez et al. 2006; Sun et al. 2008; Lee et al. 2010; Shachar et al. 2011; Zimprich et al. 2011; Coen et al. 2012).”
BackgroundNeuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Wong, Y. C., Luk, K., Purtell, K., Burke Nanni, S., Stoessl, A. J., Trudeau, L., Yue, Z., Krainc, D., Oertel, W., Obeso, J. A., et al. (2019) · Movement Disorders · doi:10.1002/mds.27823 · Cited by 122
LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance
Rothaug, M., Zunke, F., Mazzulli, J. R., Schweizer, M., Altmeppen, H., Lüllmann-Rauch, R., Kallemeijn, W. W., Gaspar, P., Aerts, J. M., Glatzel, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405700111 · Cited by 122
Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease
Pacelli, C., Rasmo, D. D., Signorile, A., Grattagliano, I., Tullio, G. D., D’Orazio, A., Nico, B., Comi, G. P., Ronchi, D., Ferranini, E., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.022 · Cited by 133
Stamelou, M., Quinn, N. P., & Bhatia, K. P. (2013) · Movement Disorders · doi:10.1002/mds.25509 · Cited by 130
Lysosome‐dependent pathways as a unifying theme in Parkinson's disease
Tofaris, G. K. (2012) · Movement Disorders · doi:10.1002/mds.25136 · Cited by 118
Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation
Tsunemi, T., Ishiguro, Y., Yoroisaka, A., Valdez, C., Miyamoto, K., Ishikawa, K., Saiki, S., Akamatsu, W., Hattori, N., & Krainc, D. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0954-20.2020 · Cited by 117
Park, J., Mehta, P., Cooper, A. A., Veivers, D., Heimbach, A., Stiller, B., Kubisch, C., Fung, V. S., Krainc, D., Mackay‐Sim, A., et al. (2011) · Human Mutation · doi:10.1002/humu.21527 · Cited by 118
Self-citationMitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration
Audano, M., Schneider, A., & Mitro, N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14471 · Cited by 123
Ryter, S. W., Bhatia, D., & Choi, M. E. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7518 · Cited by 114
Key genes and convergent pathogenic mechanisms in Parkinson disease
Coukos, R., & Krainc, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00812-2 · Cited by 127
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
Niemann, N., & Jankovic, J. J. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.025 · Cited by 135
Parkinson’s disease: experimental models and reality
Jiang, P., & Dickson, D. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1788-5 · Cited by 111
New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
Zhang, G., Xia, Y., Wan, F., Ma, K., Guo, X., Kou, L., Yin, S., Han, C., Liu, L., Huang, J., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00370 · Cited by 112
ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress
Vrijsen, S., Besora-Casals, L., van Veen, S., Zielich, J., den Haute, C. V., Hamouda, N. N., Fischer, C. A., Ghesquière, B., Tournev, I., Agostinis, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922342117 · Cited by 119
Clinical spectrum of Kufor‐Rakeb syndrome in the Chilean kindred with ATP13A2 mutations
Behrens, M. I., Brüggemann, N., Chaná, P., Venegas, P., Kägi, M., Parrao, T., Orellana, P., Cristián Garrido, I., Rojas, C., Hauke, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.22996 · Cited by 125
Self-citationATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome–lysosome fusion
Wang, R., Tan, J., Chen, T., Han, H., Tian, R., Tan, Y., Wu, Y., Cui, J., Chen, F., Li, J., et al. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201804165 · Cited by 108
Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
Chai, C., & Lim, K. (2014) · Current Genomics · doi:10.2174/1389202914666131210195808 · Cited by 135
Evans, J. A., Mendonca, P., & Soliman, K. F. A. (2022) · Nutrients · doi:10.3390/nu14112228 · Cited by 119
Impact of recent genetic findings in Parkinson??s disease
Klein, C., & Lohmann-Hedrich, K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281e6692b · Cited by 141
Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection
Vrijsen, S., Houdou, M., Cascalho, A. C. C., Eggermont, J., & Vangheluwe, P. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-071322-021330 · Cited by 120
Drosophila as a Model to Study Mitochondrial Dysfunction in Parkinson's Disease
Guo, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009944 · Cited by 105
Disease model organism for Parkinson disease: Drosophila melanogaster
Aryal, B., & Lee, Y. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.4.204 · Cited by 111
“Moreover, mutations in parkin (PARK2) (9), DJ-1 (PARK7) (10), pink1 (PARK6) (11), DNAJC6 (PARK19) (12), SYANJ1 (PARK20) (13), and ATP13A2 (PARK9) (14) are associated with”
Neuronal XBP-1 Activates Intestinal Lysosomes to Improve Proteostasis in C. elegans
Imanikia, S., Özbey, N. P., Krueger, C., Casanueva, M. O., & Taylor, R. C. (2019) · Current Biology · doi:10.1016/j.cub.2019.06.031 · Cited by 113
Genetic neuropathology of Parkinson's disease.
Cookson, M., Hardy, J., & Lewis, P. A. (2008) · PubMed Central · Cited by 135
Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases
Novellino, F., Saccà, V., Donato, A., Zaffino, P., Spadea, M. F., Vismara, M., Arcidiacono, B., Malara, N., Presta, I., & Donato, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031115 · Cited by 101
MitoSegNet: Easy-to-use Deep Learning Segmentation for Analyzing Mitochondrial Morphology
Fischer, C. A., Besora-Casals, L., Rolland, S. G. M., Haeussler, S., Singh, K., Duchen, M. R., Conradt, B., & Marr, C. (2020) · iScience · doi:10.1016/j.isci.2020.101601 · Cited by 115
Autosomal recessive parkinsonism
Bonifati, V. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70004-9 · Cited by 108
Protein folding diseases and neurodegeneration: Lessons learned from yeast
Winderickx, J., Delay, C., Vos, A. D., Klinger, H., Pellens, K., Vanhelmont, T., LEUVEN, F. V., & Zabrocki, P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.020 · Cited by 125
Emerging Roles of S -Nitrosylation in Protein Misfolding and Neurodegenerative Diseases
Nakamura, T., & Lipton, S. A. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1858 · Cited by 107
Transmission of α-synuclein seeds in neurodegenerative disease: recent developments
Karpowicz, R. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0195-z · Cited by 103
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Hallett, P. J., Engelender, S., & Isacson, O. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1532-2 · Cited by 104
Muñoz, V. F. L., & Paricio, N. (2011) · Parkinson s Disease · doi:10.4061/2011/520640 · Cited by 112
Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications
Balestrino, R., & Schapira, A. H. V. (2018) · The Neuroscientist · doi:10.1177/1073858417748875 · Cited by 95
Li, W., Fu, Y., Halliday, G. M., & Sue, C. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.612476 · Cited by 113
Mitochondrial Quality Control and Dynamics in Parkinson's Disease
McCoy, M. K., & Cookson, M. R. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4019 · Cited by 101
Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability
Santoro, L., Breedveld, G. J., Manganelli, F., Iodice, R., Pisciotta, C., Nolano, M., Punzo, F., Quarantelli, M., Pappatà, S., Di Fonzo, A., et al. (2011) · neurogenetics · doi:10.1007/s10048-010-0259-0 · Cited by 103
Genetics of neurodegeneration with brain iron accumulation
Gregory, A., & Hayflick, S. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0181-3 · Cited by 104
Kett, L. R., Stiller, B., Bernath, M. M., Tasset, I., Blesa, J., Jackson-Lewis, V., Chan, R. B., Zhou, B., Di Paolo, G., Przedborski, S., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0632-14.2015 · Cited by 100
Self-citationNakamura, T., & Lipton, S. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3570 · Cited by 104
Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses
Mukherjee, A. B., Appu, A. P., Sadhukhan, T., Casey, S., Mondal, A., Zhang, Z., & Bagh, M. B. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0300-6 · Cited by 96
Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity
Zhang, Z., Miah, M. R., Culbreth, M. E., & Aschner, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1844-x · Cited by 107
van Dijk, K. D., Persichetti, E., Chiasserini, D., Eusebi, P., Beccari, T., Calabresi, P., Berendse, H. W., Parnetti, L., & van de Berg, W. D. J. (2013) · Movement Disorders · doi:10.1002/mds.25495 · Cited by 101
Mechanisms of Gene-Environment Interactions in Parkinson’s Disease
Fleming, S. M. (2017) · Current Environmental Health Reports · doi:10.1007/s40572-017-0143-2 · Cited by 110
A lipid switch unlocks Parkinson’s disease-associated ATP13A2
Holemans, T., Sørensen, D. M., van Veen, S., Martin, S., Hermans, D., Kemmer, G. C., Van den Haute, C., Baekelandt, V., Günther Pomorski, T., Agostinis, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508220112 · Cited by 96
Mitochondria-Targeted Protective Compounds in Parkinson’s and Alzheimer’s Diseases
Fernández-Moriano, C., González-Burgos, E., & Gómez-Serranillos, M. P. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/408927 · Cited by 94
Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore
Lin, C. H., Tan, E. K., Chen, M. L., Tan, L. C., Lim, H. Q., Chen, G. S., & Wu, R. M. (2008) · Neurology · doi:10.1212/01.wnl.0000335167.72412.68 · Cited by 102
Autophagic pathways in Parkinson disease and related disorders
Xilouri, M., & Stefanis, L. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001803 · Cited by 113
Hatano, T., Kubo, S., Sato, S., & Hattori, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06403.x · Cited by 120
Helley, M., Pinnell, J. R., Sportelli, C., & Tieu, K. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00177 · Cited by 110
Genes associated with Parkinson's disease: regulation of autophagy and beyond
Beilina, A., & Cookson, M. R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13266 · Cited by 93
Matsui, H., Itô, J., Matsui, N., Uechi, T., Onodera, O., & Kakita, A. (2021) · Nature Communications · doi:10.1038/s41467-021-23452-x · Cited by 109
Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models
Huarcaya, S. P., Drobny, A., Marques, A. R. A., Spiezio, A. D., Dobert, J. P., Balta, D., Werner, C. D., Rizo, T., Gallwitz, L., Bub, S., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2045534 · Cited by 105
PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort
Shi, C., Tang, B., Wang, L., Lv, Z., Wang, J., Luo, L.-Z., Shen, L. H., Jiang, H. F., Yan, X., Pan, Q., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318221acd3 · Cited by 98
Neurodegeneration with Brain Iron Accumulation: Genetic Diversity and Pathophysiological Mechanisms
Meyer, E., Kurian, M. A., & Hayflick, S. J. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-025011 · Cited by 100
Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease
Blommer, J., Pitcher, T., Mustapic, M., Eren, E., Yao, P. J., Vreones, M. P., Pucha, K. A., Dalrymple-Alford, J., Shoorangiz, R., Meissner, W. G., et al. (2023) · Brain · doi:10.1093/brain/awac258 · Cited by 92
Nishito, Y., Tsuji, N., Fujishiro, H., Takeda, T.-A., Yamazaki, T., Teranishi, F., Okazaki, F., Matsunaga, A., Tuschl, K., Rao, R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.728014 · Cited by 94
PARK9 -LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE
Ning, Y. P., Kanai, K., Tomiyama, H., Li, Y., Funayama, M., Yoshino, H., Sato, S., Asahina, M., Kuwabara, S., Takeda, A., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000310427.72236.68 · Cited by 95
Settivari, R. S., LeVora, J., & Nass, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051409 · Cited by 100
Toxin-Induced and Genetic Animal Models of Parkinson's Disease
Hisahara, S., & Shimohama, S. (2011) · Parkinson's Disease · doi:10.4061/2011/951709 · Cited by 91
Current perspective of mitochondrial biology in Parkinson's disease
Kaidery, N. A., & Thomas, B. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.03.001 · Cited by 100
Hinarejos, I., Machuca, C., Sancho, P., & Espinós, C. (2020) · Antioxidants · doi:10.3390/antiox9101020 · Cited by 101
Roles of BLOC-1 and Adaptor Protein-3 Complexes in Cargo Sorting to Synaptic Vesicles
Newell-Litwa, K., Salazar, G., Smith, Y., & Faundez, V. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-05-0456 · Cited by 95
Manganese Homeostasis and Transport
Roth, J. A., Ponzoni, S., & Aschner, M. (2012) · Metal ions in life sciences · doi:10.1007/978-94-007-5561-1_6 · Cited by 104
Monaco, A., & Fraldi, A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00037 · Cited by 95
Brüggemann, N., Hagenah, J., Reetz, K., Schmidt, A., Kasten, M., Buchmann, I., Eckerle, S., Bähre, M., Münchau, A., Djarmati, A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.281 · Cited by 90
Self-citationR632W mutation in PLA2G6 segregates with dystonia‐parkinsonism in a consanguineous Iranian family
Sina, F., Shojaee, S. M., Elahi, E., & Paisán‐Ruiz, C. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02356.x · Cited by 93
Scheper, W., & Hoozemans, J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787458506 · Cited by 90
Metadata
- Authors
- Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I., & Kubisch, C.
- Affiliations
- University of Cologne (DE)
- Philipps University of Marburg (DE)
- University of Leeds (GB)
- Centro de Estudios Científicos (CL)
- University of Bonn (DE)
- King Hussein Medical Center (JO)
- Pinderfields Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Kubisch, Christian
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-09-10
- Volume
- 38
- Issue
- 10
- Pages
- 1184-1191
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2139369185
- Cited by
- 1,208
- References
- 30
- Citations by year
- 2026: 42 · 2025: 44 · 2024: 39 · 2023: 49 · 2022: 45 · 2021: 70 · 2020: 73 · 2019: 69 · 2018: 54 · 2017: 64 · 2016: 76 · 2015: 59 · 2014: 57 · 2013: 71 · 2012: 64
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion)
- Funders
- Tinker Foundation
- Wellcome Trust
- Royal Society
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Rheinische Friedrich-Wilhelms-Universität Bonn
- National Institutes of Health
- Directorate for Biological Sciences
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- ATP13A2, P-type ATPase, Kufor-Rakeb syndrome, PARK9, autosomal recessive inheritance, loss-of-function mutations, neurodegeneration, endoplasmic reticulum retention, proteasomal degradation, protein misfolding
- MeSH terms
- Adenosine Triphosphatases, Dementia, Endoplasmic Reticulum, Female, Proton-Translocating ATPases, Humans, Lysosomes, Male, Mesencephalon, Mutation, Neurons, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.